Evidence for novel non-angiogenic pathway in breast-cancer metastasis. Breast Cancer Progression Working Party.
Where this comes from
- Record sourced from PubMed, PMID 10832831.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We have reported that angiogenic primary breast carcinoma can relapse not only as angiogenic, but also as non-angiogenic, lung metastases. This non-angiogenic pathway seems to be a novel pathway of cancer progression, and such tumours are likely to be resistant to antiangogenic treatment.